Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMPHENOL CORP /DE/ Capital/Financing Update 2022

Apr 21, 2022

29818_rns_2022-04-21_246ab844-a8f2-4a6c-966a-b2d7dc25e661.zip

Capital/Financing Update

Open in viewer

Opens in your device viewer

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington , D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15( d ) of

The Securities Exchange Act of 1934

Date of report (Date of earliest event reported) April 19, 2022

AMPHENOL CORPORATION

(Exact Name of Registrant as Specified in Charter)

Delaware 1-10879 22-2785165
(State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.)
358 Hall Avenue , Wallingford , Connecticut 06492
(Address of Principal Executive Offices) (Zip Code)

Registrant’s telephone number, including area code: ( 203 ) 265-8900

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name of each exchange on which registered
Class A
Common Stock, $0.001 par value APH New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ¨

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

Item 1.01 Entry into a Material Definitive Agreement.

On April 19, 2022, Amphenol Corporation (the “Company”) entered into a two-year, $750 million unsecured delayed draw term loan credit agreement among the Company, certain subsidiaries of the Company, a syndicate of financial institutions and BNP Paribas, acting as administrative agent (the “2022 Term Loan”), which is scheduled to mature on April 19, 2024. The 2022 Term Loan was undrawn at closing and may be drawn on up to five occasions over the life of the facility. The 2022 Term Loan may be repaid at any time without premium or penalty and, once prepaid, cannot be reborrowed. Interest rates under the 2022 Term Loan are based on a spread over either the base rate or the adjusted term SOFR, which spread varies based on the Company’s debt rating. The proceeds from the 2022 Term Loan are expected to be used for general corporate purposes.

A copy of the 2022 Term Loan is attached hereto as Exhibit 10.1 and is incorporated by reference herein.

Item 2.03 Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.

The information under Item 1.01 of this Current Report is incorporated by reference herein.

Item 9.01 Financial Statements and Exhibits.

Exhibit No. Description

| 10.1* | Term Loan Credit Agreement dated April 19, 2022 among the Company, certain subsidiaries of the
Company, a syndicate of financial institutions and BNP Paribas, acting as the administrative agent. |
| --- | --- |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |

  • Certain schedules and exhibits have been omitted pursuant to Item 601(a)(5) of Regulation S-K.

Field: Page; Sequence: 2; Options: NewSection

Field: /Page

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

AMPHENOL CORPORATION
By: /s/ Craig A. Lampo
Craig A. Lampo
Senior Vice President and Chief Financial Officer

Date: April 21, 2022

Field: Page; Sequence: 3; Options: Last

Field: /Page